Antithrombin deficiency in special clinical syndromes--Part I: panel discussion.
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D002404:Catheterization / Q000009:adverse effects; D002648:Child; D002986:Clinical Trials as Topic; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D009104:Multiple Trauma / Q000097:blood / Q000401:mortality; D010818:Practice Patterns, Physicians'; D011654:Pulmonary Edema / Q000097:blood; D018805:Sepsis / Q000097:blood; D013927:Thrombosis / Q000517:prevention & control; D000515:alpha 1-Antitrypsin / Q000032:analysis; D019896:alpha 1-Antitrypsin Deficiency
D000925:Anticoagulants; D000515:alpha 1-Antitrypsin; D000990:Antithrombin III; D006493:Heparin